Whilst no absolute contraindication exists between these medications, combining them requires careful medical supervision
Food and Drug Administrationapproved indications for Type 2 diabetes or obesity meeting specific body mass index thresholds, supported by standardized medical documentation
As a weekly injection, it has resulted in an average weight loss of 20.9% in clinical trials
Where to get tirzepatide should fundamentally mean cooperating with providers genuinely prioritizing your health and wellbeing
Ongoing trials with semaglutide and tirzepatide Currently, several studies are examining more recent GLP-1 drugs
According to Raj Singh, MD, FACP, FASN , an internal medicine specialist, nephrologist, and obesity medicine specialist at Healor Health, people taking GLP-1s should expect to stay on them long-term or even indefinitely